Allaxys Communications --- Transponder V --- Allaxys Forum 1
Aus der Forschung => Neues aus der Forschung => Topic started by: ama on September 07, 2011, 10:34:09 AM
-
[*QUOTE*]
------------------------------------------------------------------------------------
Cross posted from Nature Reviews Drug Discovery on behalf of Asher Mullard.
Bayer halts nearly two-thirds of its target-validation projects because in-house experimental findings fail to match up with published literature claims, finds a first-of-a-kind analysis on data irreproducibility.
------------------------------------------------------------------------------------
[*/QUOTE*]
more:
http://blogs.nature.com/news/2011/09/reliability_of_new_drug_target.html?utm_source=feedburner&utm_medium=twitter&utm_campaign=Feed%3A+news%2Frss%2Fthe_great_beyond+%28Nature+News+Blog+-+Blog+Posts%29&WT.mc_id=TWT_NatureNews (http://blogs.nature.com/news/2011/09/reliability_of_new_drug_target.html?utm_source=feedburner&utm_medium=twitter&utm_campaign=Feed%3A+news%2Frss%2Fthe_great_beyond+%28Nature+News+Blog+-+Blog+Posts%29&WT.mc_id=TWT_NatureNews)